BridgeMD
New treatment option for Venous Thromboembolic Event
Official title Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management
ClinicalTrials.gov ID: NCT07464808
What this study is testing
- What it's testing
- This study aims to compare the efficacy of anti-Xa based versus weight-based enoxaparin dosing and to evaluate anti-Xa levels as a predictive tool for clinical outcomes in burn patients
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- Adults (≥21 years) admitted to the burn unit with thermal burns ≥20% TBSA and \< 60%.
- Admission to BICU within 48 hours of burn injury.
- Indication for VTE prophylaxis (e.g., immobilized, surgical intervention).
- Ability to provide informed consent
You likely can't join if
- Pre-existing coagulopathy or anticoagulant therapy prior to injury.
- Patients with severe comorbidities (e.g., end-stage renal failure, advanced malignancy, hepatic disease).
- Need for therapeutic anticoagulant therapy.
- patients with extremes of weight, (45kg \>=weight \>= 150kg).
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Abbassia, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Abbassia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.